Pancreatic Cancer Research

ResearcherUniversité Libre de BruxellesActive in the last 2 years

Francesco Sclafani

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0251-2627; OpenAlex author ID A5079301374. Sources: OpenAlex.

Their work

Papers
8 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
54
Papers, trials and grants by year

2015: 1 paper · 2016: 1 paper · 2017: none · 2018: none · 2019: 1 paper · 2020: 1 paper · 2021: 3 papers · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 8

  1. Digital and AI-assisted multimodal supportive care, combining physical activity, nutrition, and pain management during chemotherapy for advanced pancreatic can… Co-author DOI 10.1186/s12885-025-14867-6↗
  2. Leukemia Inhibitory Factor: A Potential Biomarker and Therapeutic Target in Pancreatic Cancer. Co-author DOI 10.1007/s00005-021-00605-w↗
  3. European Cancer Organisation Essential Requirements for Quality Cancer Care (ERQCC): Pancreatic Cancer. First author DOI 10.1016/j.ctrv.2021.102208↗
  4. Modulation of pancreatic cancer cell sensitivity to FOLFIRINOX through microRNA-mediated regulation of DNA damage. Co-author DOI 10.1038/s41467-021-27099-6↗
  5. Bratislava Statement: consensus recommendations for improving pancreatic cancer care. Co-author DOI 10.1136/esmoopen-2020-001051↗
  6. New therapeutic targets in pancreatic cancer. Co-author DOI 10.1016/j.ctrv.2019.101926↗
  7. International Association of Pancreatology (IAP)/European Pancreatic Club (EPC) consensus review of guidelines for the treatment of pancreatic cancer. Co-author DOI 10.1016/j.pan.2015.10.013↗
  8. Management of metastatic pancreatic cancer: Current treatment options and potential new therapeutic targets. Co-author DOI 10.1016/j.critrevonc.2015.03.008↗

Closest collaborators

The 25 strongest of 54 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Cindy Neuzillet · 2 shared papers, 2021–2025 · strength 0.26
  2. Thomas Baptist Brunner · 3 shared papers, 2016–2021 · strength 0.22
  3. David Cunningham · 3 shared papers, 2015–2021 · strength 0.20
  4. Maciej Borowiec · 1 shared paper, 2021 · strength 0.19
  5. Ewa Wrona · 1 shared paper, 2021 · strength 0.19
  6. Stefano Partelli · 2 shared papers, 2020–2021 · strength 0.18
  7. Markus Hermann Moehler · 1 shared paper, 2025 · strength 0.16
  8. Barlo Hillen · 1 shared paper, 2025 · strength 0.16
  9. Irit Ben‐Aharon · 1 shared paper, 2025 · strength 0.16
  10. Eva Ester Molina Beltran · 1 shared paper, 2025 · strength 0.16
  11. Naureen Starling · 2 shared papers, 2015–2021 · strength 0.16
  12. Andrew Victor Biankin · 2 shared papers, 2016–2021 · strength 0.13
  13. Aldo Scarpa Scarpa · 2 shared papers, 2016–2021 · strength 0.13
  14. Marc Zins · 1 shared paper, 2021 · strength 0.10
  15. Philip M. Poortmans · 1 shared paper, 2021 · strength 0.10
  16. Sorin Traian Barbu · 1 shared paper, 2021 · strength 0.10
  17. Hanna E. Seppänen · 1 shared paper, 2021 · strength 0.10
  18. Giulia Angela Zamboni · 1 shared paper, 2021 · strength 0.10
  19. Ken Herrmann · 1 shared paper, 2021 · strength 0.10
  20. Giulia Martina Cavestro · 1 shared paper, 2021 · strength 0.10
  21. Eva Karamitopoulou · 1 shared paper, 2021 · strength 0.10
  22. Božena Smolková · 1 shared paper, 2020 · strength 0.08
  23. Joan Prades · 1 shared paper, 2020 · strength 0.08
  24. Dirk Arnold · 1 shared paper, 2020 · strength 0.08
  25. Cristina Coll-Ortega · 1 shared paper, 2020 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.